Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cardiovascular Translational Research
Published in: Journal of Cardiovascular Translational Research 5-6/2016

01-12-2016 | Correspondence

Reply: Bioresorbable Scaffolds in Cardiac Allograft Vasculopathy—Searching for the Holy Grail Facing the challenge of the “Perilous Seat”

Authors: Michele Pighi, Fabrizio Tomai, Flavio Ribichini

Published in: Journal of Cardiovascular Translational Research | Issue 5-6/2016

Login to get access

Excerpt

We thank Dr. Leite and Colleagues for their interest in our recently published Cardiac Allograft Reparative Therapy (CART) study protocol [1]. …
Literature
1.
Pighi, M., Tomai, F., Petrolini, A., De Luca, L., Tarantini, G., Barioli, A., et al. (2016). Everolimus-eluting bioresorbable vascular scaffold system in the treatment of cardiac allograft vasculopathy: the CART (Cardiac Allograft Reparative Therapy) prospective multicenter pilot study. Journal of Cardiovascular Translational Research, 9(1), 40–48.CrossRefPubMed
2.
Diletti, R., Farooq, V., Girasis, C., Bourantas, C., Onuma, Y., Heo, J. H., et al. (2013). Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart, 99(2), 98–105.CrossRefPubMed
3.
Latini, R. A., Granata, F., Ielasi, A., Varricchio, A., Moscarella, E., Tespili, M., et al. (2016). Bioresorbable vascular scaffolds for small vessels coronary disease: the BVS-save registry. Catheterization and Cardiovascular Interventions, 88(3), 380–387.CrossRefPubMed
4.
Ellis, S. G., Kereiakes, D. J., Metzger, D. C., Caputo, R. P., Rizik, D. G., Teirstein, P. S., et al. (2015). Everolimus-eluting bioresorbable scaffolds for coronary artery disease. The New England Journal of Medicine, 373(20), 1905–1915.CrossRefPubMed
5.
Tomai, F., De Luca, L., Petrolini, A., Di Vito, L., Ghini, A. S., Corvo, P., et al. (2016). Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation. Journal of Heart and Lung Transplantation, 35(1), 74–79.CrossRefPubMed
Metadata
Title
Reply: Bioresorbable Scaffolds in Cardiac Allograft Vasculopathy—Searching for the Holy Grail Facing the challenge of the “Perilous Seat”
Authors
Michele Pighi
Fabrizio Tomai
Flavio Ribichini
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 5-6/2016
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-016-9714-0

Other articles of this Issue 5-6/2016

Journal of Cardiovascular Translational Research 5-6/2016 Go to the issue

Review

Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet?

Correspondence

Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure

Original Article

Rad-deletion Phenocopies Tonic Sympathetic Stimulation of the Heart

Original Article

Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT

Editorial

ST2-Based Precision Medicine in Device Management: the Next Frontier Beyond MADIT-CRT?

Original Article

A Natural Model of Mouse Cardiac Myocyte Senescence

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits